SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+30.99%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.19B
AUM Growth
+$2.19B
(+18%)
Cap. Flow
-$50.9M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
47.59%
Holding
101
New
13
Increased
23
Reduced
21
Closed
13
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$69.2M |
| 2 |
Goldman Sachs
GS
|
$42.6M |
| 3 |
TSMC
TSM
|
$40.4M |
| 4 |
Ferguson
FERG
|
$34M |
| 5 |
Apollo Global Management
APO
|
$32.5M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$91M |
| 2 |
Advanced Micro Devices
AMD
|
$53.5M |
| 3 |
Wynn Resorts
WYNN
|
$42.5M |
| 4 |
NVIDIA
NVDA
|
$38.5M |
| 5 |
Amazon
AMZN
|
$38.2M |
Sector Composition
| 1 | Healthcare | 68.4% |
| 2 | Technology | 8.43% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Communication Services | 5.73% |
| 5 | Industrials | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.4B
| $29.4M | 1.33% |
63,460
+25,920
| +69% | +$12M |
|
27
Cigna
CI
$80.3B
| $28.8M | 1.3% |
96,300
+92,300
| +2,308% | +$27.6M |
|
28
Arcutis Biotherapeutics
ARQT
$1.86B
| $27.4M | 1.24% |
8,473,101
+7,337,874
| +646% | +$23.7M |
|
29
Verizon
VZ
$186B
| $27M | 1.22% |
+716,850
| New | +$27M |
|
30
Elevance Health
ELV
$71.8B
| $25.3M | 1.15% |
53,735
+50,725
| +1,685% | +$23.9M |
|
31
Sutro Biopharma
STRO
$72.7M
| $24.8M | 1.12% |
5,778,188
-105,505
| -2% | -$453K |
|
32
Cogent Biosciences
COGT
$1.69B
| $21.8M | 0.99% |
3,710,539
+657,239
| +22% | +$3.86M |
|
33
AT&T
T
$209B
| $20.5M | 0.93% |
+1,220,080
| New | +$20.5M |
|
34
argenx
ARGX
$43.6B
| $20.4M | 0.92% |
53,700
+50,900
| +1,818% | +$19.4M |
|
35
Chipotle Mexican Grill
CMG
$56.5B
| $19.9M | 0.9% |
8,710
-11,690
| -57% | -$26.7M |
|
36
Hilton Worldwide
HLT
$64.9B
| $19.9M | 0.9% |
109,262
-4,700
| -4% | -$856K |
|
37
Arcus Biosciences
RCUS
$1.13B
| $18.3M | 0.83% |
957,304
+360,205
| +60% | +$6.88M |
|
|
MREO
38
Mereo BioPharma
MREO
$272M
| $17M | 0.77% |
7,370,838
+6,400
| +0.1% | +$14.8K |
|
|
BCYC
39
Bicycle Therapeutics
BCYC
$511M
| $16.5M | 0.75% |
914,476
-96,500
| -10% | -$1.74M |
|
40
Global Payments
GPN
$21.5B
| $14.3M | 0.65% |
112,380
-172,108
| -60% | -$21.9M |
|
41
Johnson & Johnson
JNJ
$427B
| $14.1M | 0.64% |
90,097
| – | – |
|
42
Zura Bio
ZURA
$133M
| $13.3M | 0.6% |
2,850,000
| – | – |
|
43
InflaRx
IFRX
$108M
| $9.35M | 0.42% |
5,733,910
| – | – |
|
44
Elanco Animal Health
ELAN
$9.12B
| $9.15M | 0.41% |
614,300
+77,800
| +15% | +$1.16M |
|
45
Agios Pharmaceuticals
AGIO
$2.19B
| $8.9M | 0.4% |
399,451
-54,549
| -12% | -$1.21M |
|
46
Sanofi
SNY
$121B
| $8.5M | 0.38% |
171,001
+54,960
| +47% | +$2.73M |
|
47
AnaptysBio
ANAB
$569M
| $7.6M | 0.34% |
354,872
-124,573
| -26% | -$2.67M |
|
48
ProKidney
PROK
$319M
| $6.88M | 0.31% |
3,867,847
+4
| +0% | +$7 |
|
49
Kezar Life Sciences
KZR
$28.9M
| $6.79M | 0.31% |
7,167,591
| – | – |
|
50
UnitedHealth
UNH
$281B
| $6.75M | 0.31% |
12,823
-14,400
| -53% | -$7.58M |
|